These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 37858111)
1. Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma. Xu Y; Li Z; Zhou Y; Yang Y; Ouyang J; Li L; Huang Z; Ye F; Ying J; Zhao H; Zhou J; Zhao X BMC Cancer; 2023 Oct; 23(1):1009. PubMed ID: 37858111 [TBL] [Abstract][Full Text] [Related]
2. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649 [TBL] [Abstract][Full Text] [Related]
3. Prediction of Microvascular Invasion in Combined Hepatocellular-Cholangiocarcinoma Based on Pre-operative Clinical Data and Contrast-Enhanced Ultrasound Characteristics. Chen Y; Lu Q; Zhu Y; Huang B; Dong Y; Wang W Ultrasound Med Biol; 2022 Jul; 48(7):1190-1201. PubMed ID: 35397928 [TBL] [Abstract][Full Text] [Related]
4. Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors. Wang Y; Zhu GQ; Zhou CW; Li N; Yang C; Zeng MS Eur Radiol; 2022 Aug; 32(8):5166-5178. PubMed ID: 35316365 [TBL] [Abstract][Full Text] [Related]
5. Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma. Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H Abdom Radiol (NY); 2024 Feb; 49(2):425-436. PubMed ID: 37889266 [TBL] [Abstract][Full Text] [Related]
6. A Bayesian Network Prediction Model for Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma: A Multi-institutional Study. Li Q; Zhang J; Cai Z; Chen C; Wu H; Qiu Y; Song T; Mao X; He Y; Cheng Z; Zhai W; Li J; Si S; Zhang D; Geng Z; Tang Z World J Surg; 2023 Mar; 47(3):773-784. PubMed ID: 36607391 [TBL] [Abstract][Full Text] [Related]
8. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis. Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787 [No Abstract] [Full Text] [Related]
9. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma. Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151 [TBL] [Abstract][Full Text] [Related]
10. Association Between MRI Radiomics and Intratumoral Tertiary Lymphoid Structures in Intrahepatic Cholangiocarcinoma and Its Prognostic Significance. Xu Y; Li Z; Yang Y; Zhang Y; Li L; Zhou Y; Ouyang J; Huang Z; Wang S; Xie L; Ye F; Zhou J; Ying J; Zhao H; Zhao X J Magn Reson Imaging; 2024 Aug; 60(2):715-728. PubMed ID: 37942838 [TBL] [Abstract][Full Text] [Related]
11. Predictive factors of microvascular invasion in patients with intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance images. Chen S; Wan L; Zhao R; Peng W; Li Z; Zou S; Zhang H Abdom Radiol (NY); 2023 Apr; 48(4):1306-1319. PubMed ID: 36872324 [TBL] [Abstract][Full Text] [Related]
12. Preoperative evaluation of MRI features and inflammatory biomarkers in predicting microvascular invasion of combined hepatocellular cholangiocarcinoma. Zhang J; Dong W; Liu W; Fu J; Liao T; Li Y; Huo L; Jia N Abdom Radiol (NY); 2024 Mar; 49(3):710-721. PubMed ID: 38112787 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China. Chen Y; Liu H; Zhang J; Wu Y; Zhou W; Cheng Z; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zeng Y; Liu J BMC Cancer; 2021 Dec; 21(1):1299. PubMed ID: 34863147 [TBL] [Abstract][Full Text] [Related]
14. A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma. Xu Y; Li Z; Yang Y; Li L; Zhou Y; Ouyang J; Huang Z; Wang S; Xie L; Ye F; Zhou J; Ying J; Zhao H; Zhao X Insights Imaging; 2023 Oct; 14(1):173. PubMed ID: 37840098 [TBL] [Abstract][Full Text] [Related]
15. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study. Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726 [TBL] [Abstract][Full Text] [Related]
16. A Multiparametric Fusion Deep Learning Model Based on DCE-MRI for Preoperative Prediction of Microvascular Invasion in Intrahepatic Cholangiocarcinoma. Gao W; Wang W; Song D; Wang K; Lian D; Yang C; Zhu K; Zheng J; Zeng M; Rao SX; Wang M J Magn Reson Imaging; 2022 Oct; 56(4):1029-1039. PubMed ID: 35191550 [TBL] [Abstract][Full Text] [Related]
17. Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data. Zhang J; Dong W; Li Y; Fu J; Jia N Eur J Radiol; 2023 Jun; 163():110839. PubMed ID: 37121101 [TBL] [Abstract][Full Text] [Related]
18. Synergistic impact of resection margin and microscopic vascular invasion for patients with HBV-related intrahepatic cholangiocarcinoma. Lu WF; Chen PQ; Yan K; Wu YC; Liang L; Yuan JY; Fu Y; Zhang HB Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):575-582. PubMed ID: 33899638 [TBL] [Abstract][Full Text] [Related]
19. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma. Ding GY; Ma JQ; Yun JP; Chen X; Ling Y; Zhang S; Shi JY; Chang YQ; Ji Y; Wang XY; Tan WM; Yuan KF; Yan B; Zhang XM; Liang F; Zhou J; Fan J; Zeng Y; Cai MY; Gao Q J Hepatol; 2022 Mar; 76(3):608-618. PubMed ID: 34793865 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of nomogram to predict very early recurrence of combined hepatocellular-cholangiocarcinoma after hepatic resection: a multi-institutional study. Wu Y; Liu H; Zeng J; Chen Y; Fang G; Zhang J; Zhou W; Zeng Y; Liu J World J Surg Oncol; 2022 Feb; 20(1):60. PubMed ID: 35227269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]